Helmholtz-Zentrum Dresden-Rossendorf, PET Center, Institute of Radiopharmaceutical Cancer Research, Germany.
Department of Radiology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
Radiother Oncol. 2018 Jul;128(1):121-127. doi: 10.1016/j.radonc.2017.11.033. Epub 2018 Jan 19.
To compare the structural and hemodynamic changes of healthy brain tissue in the cerebral hemisphere contralateral to the tumor following photon and proton radiochemotherapy.
Sixty-seven patients (54.9 ±14.0 years) diagnosed with glioblastoma undergoing adjuvant photon (n = 47) or proton (n = 19) radiochemotherapy with temozolomide after tumor resection underwent T1-weighted and arterial spin labeling MRI. Changes in volume and perfusion before and 3 to 6 months after were compared between therapies.
A decrease in gray matter (GM) (-2.2%, P<0.001) and white matter (WM) (-1.2%, P<0.001) volume was observed in photon-therapy patients compared to the pre-radiotherapy baseline. In contrast, for the proton-therapy group, no significant differences in GM (0.3%, P = 0.64) or WM (-0.4%, P = 0.58) volume were observed. GM volume decreased with 0.9% per 10 Gy dose increase (P<0.001) and differed between the radiation modalities (P<0.001). Perfusion decreased in photon-therapy patients (-10.1%, P = 0.002), whereas the decrease in proton-therapy patients, while comparable in magnitude, did not reach statistical significance (-9.1%, P = 0.12). There was no correlation between perfusion decrease and either dose (P = 0.64) or radiation modality (P = 0.94).
Our results show that the tissue volume decrease depends on radiation dose delivered to the healthy hemisphere and differs between treatment modalities. In contrast, the decrease in perfusion was comparable for both irradiation modalities. We conclude that proton therapy may reduce brain-volume loss when compared to photon therapy.
比较肿瘤对侧大脑半球在光子和质子放化疗后健康脑组织的结构和血流动力学变化。
67 名(54.9±14.0 岁)诊断为胶质母细胞瘤的患者在肿瘤切除后接受辅助光子(n=47)或质子(n=19)放化疗联合替莫唑胺治疗,行 T1 加权和动脉自旋标记 MRI。比较两种治疗方法治疗前后 3 至 6 个月的体积和灌注变化。
与放疗前基线相比,光子治疗组的灰质(GM)(-2.2%,P<0.001)和白质(WM)(-1.2%,P<0.001)体积减少。相比之下,质子治疗组 GM(0.3%,P=0.64)或 WM(-0.4%,P=0.58)体积无显著差异。GM 体积随 10 Gy 剂量增加减少 0.9%(P<0.001),且两种放射方式之间存在差异(P<0.001)。光子治疗组的灌注减少(-10.1%,P=0.002),而质子治疗组的灌注减少虽然程度相当,但无统计学意义(-9.1%,P=0.12)。灌注减少与剂量(P=0.64)或放射方式(P=0.94)均无相关性。
我们的结果表明,组织体积减少取决于健康半球接受的辐射剂量,并因治疗方式而异。相比之下,两种照射方式的灌注减少程度相当。我们得出结论,与光子治疗相比,质子治疗可能会减少脑体积损失。